Goldman Sachs BDC Q2 Results: Adj. EPS beats estimate
Goldman Sachs BDC delivered a second-quarter beat on both adjusted EPS and sales, surpassing analyst estimates by 19.35% and 5.13% respectively. However, both metrics declined year-over-year, with EPS down 2.63% and sales down 7.97%, indicating that the beat was driven by lowered market expectations rather than organic growth.

*this image is generated using AI for illustrative purposes only.
Goldman Sachs BDC (NYSE: GSBD) reported second-quarter adjusted earnings per share of $0.37, beating the analyst consensus estimate of $0.31 by 19.35 percent. This result represents a 2.63 percent decrease from the $0.38 per share earned in the same period last year. The company also reported quarterly sales of $83.724 million, which beat the analyst consensus estimate of $79.641 million by 5.13 percent. Despite beating estimates, sales reflect a 7.97 percent decrease from the $90.970 million recorded in the same period last year.
Financial Performance
The company’s ability to exceed analyst expectations on both earnings and revenue highlights operational efficiency despite a year-over-year decline in top-line figures. The divergence between the strong beat on estimates and the year-over-year decline suggests that market expectations had been lowered significantly prior to the release.
| Metric | Reported | Estimate | Beat/Miss | YoY Change |
|---|---|---|---|---|
| Adjusted EPS | $0.37 | $0.31 | +19.35% | -2.63% |
| Sales | $83.724M | $79.641M | +5.13% | -7.97% |
What the Numbers Show
While Goldman Sachs BDC successfully beat analyst forecasts for both adjusted earnings per share and sales, the underlying trend remains negative compared to the prior year. The 19.35 percent beat on EPS was driven by lower expectations rather than growth, as earnings fell 2.63 percent year-over-year. Similarly, the 5.13 percent sales beat masks a 7.97 percent decline in revenue from the previous year’s $90.970 million. This pattern indicates that while the company is performing better than recently anticipated, it is still contracting relative to its historical performance.
How might Goldman Sachs BDC's portfolio strategy adapt to sustain earnings growth amid declining top-line revenue?
What specific cost-cutting measures or operational efficiencies drove the 19.35% EPS beat despite a year-over-year sales decline?
Will the divergence between beating estimates and negative YoY trends influence analyst sentiment and future price targets for GSBD?


























